SIShun Iida

Shun Iida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shun Iida has a total of 401 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pathology and viral evolutionary dynamics in a hamster model of persistent SARS-CoV-2 infection

    by Wanting Wei, Makoto Kuroda, Yanan Liu, Shun Iida, Sangam Kandel, Heather Machovech, Yuichiro Hirata, Tadaki Suzuki, Katia Koelle, Zhongde Wang, et al.

    SARS-CoV-2 infection typically resolves within weeks, but rare cases of prolonged replication—sometimes exceeding a year—have been documented, particularly in immunocompromised individuals. These persistent infections pose health risks and may give rise to highly divergent variants, yet the underlying biology remains poorly understood. Here, we describe a model of SARS-CoV-2 persistence using transgenic Syrian hamsters (males) lacking the interleukin-2 receptor gamma subunit (IL2rg). Infection with the XBB.1.16 variant led to efficient viral replication in respiratory tissues by two weeks after infection, with dissemination to other sites, including the intestinal tract. Viral titers remained high in multiple tissues at 100 days after infection. Longitudinal oral swab sequencing revealed dynamic shifts in intrahost single-nucleotide variant (iSNV) frequencies, with constellations of iSNVs rising and falling together, consistent with strong genetic linkage. Synonymous and nonsynonymous mutations accumulated at similar rates, suggesting genetic drift as the dominant evolutionary force. Tissue- and swab-derived sequences revealed extensive within-host diversity and hinted at tissue-specific evolutionary trajectories. This model enables detailed investigation of SARS-CoV-2 persistence and within-host viral evolution and provides a controlled system to study how long-term replication in tissue reservoirs may contribute to viral diversification.

  • Identification of Novel Wraparound Transcripts in JC Polyomavirus

    by Shun Iida, Kenta Takahashi, Sohtaro Mine, Tadaki Suzuki, Harutaka Katano

    JC polyomavirus (JCPyV) is a ubiquitous pathogen that causes progressive multifocal leukoencephalopathy (PML). Although a recent study using next‐generation sequencing (NGS) provided detailed transcriptome atlases for polyomaviruses (PyVs) such as BK polyomavirus and simian virus 40, the transcriptome of JCPyV remains poorly characterized. Here, we conducted a comprehensive analysis using both short‐read and long‐read NGS technologies to construct a transcriptome atlas of JCPyV. RNA extracted from IMR‐32 and HEK293 cells transfected with the circular JCPyV genome was analyzed, leading to the identification of 39 previously uncharacterized viral transcripts in addition to 12 known ones. Among the novel transcripts, we identified wraparound transcripts, conserved across PyVs, which are generated through continuous, multicyclic transcription of the circular viral genome. These included both late transcripts containing leader‐to‐leader repeated sequences and SuperT transcripts with multiple LxCxE motifs. Notably, wraparound transcripts, including SuperT transcripts, were also detected in brain tissues from PML patients. Collectively, this study significantly expands our understanding of the JCPyV transcriptome, revealing the expression of wraparound transcripts in PML lesions. These findings provide valuable insights into the molecular basis of JCPyV gene expression and PML pathogenesis, potentially facilitating the development of effective countermeasures against PML.


  • Open Access

    Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients

    by Chisako Iriyama, Takaya Ichikawa, Tomokazu Tamura, Mutsumi Takahata, Takashi Ishio, Makoto Ibata, Ryuji Kawai, Mitsunaga Iwata, Masahiro Suzuki, Hirokazu Adachi, et al.

    Patients with hematologic diseases have experienced coronavirus disease 2019 (COVID-19) with a prolonged, progressive course. Here, we present clinical, pathological, and virological analyses of three cases of prolonged COVID-19 among patients undergoing treatment for B-cell lymphoma. These patients had all been treated with anti-CD20 antibody and bendamustine. Despite various antiviral treatments, high severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels persisted for >4 weeks, and two of them succumbed to COVID-19. The autopsy showed bronchopneumonia, interstitial pneumonia, alveolar hemorrhage, and fibrosis. Overlapping cytomegalovirus, fungal and/or bacterial infections were also confirmed. Sequencing of SARS-CoV-2 showed accumulation of mutations and changes in variant allele frequencies over time. NSP12 mutations V792I and M794I appeared independently in two cases as COVID-19 progressed. In vitro drug susceptibility analysis and an animal experiment using recombinant SARS-CoV-2 demonstrated that each mutation, V792 and M794I, was independently responsible for remdesivir resistance and attenuated pathogenicity. E340A, E340D, and F342INS mutations in the spike protein were found in one case, which may account for the sotrovimab resistance. Analysis of autopsy specimens indicated heterogeneous distribution of these mutations. In summary, we demonstrated temporal and spatial diversity in SARS-CoV-2 that evolved resistance to various antiviral agents in malignant lymphoma patients under immunodeficient conditions caused by certain types of immunochemotherapies. Strategies may be necessary to prevent the acquisition of drug resistance and improve outcomes, such as the selection of appropriate treatment strategies for lymphoma considering patients’ immune status and the institution of early intensive antiviral therapy.


  • Open Access

    Neutrophil adhesion to vessel walls impairs pulmonary circulation in COVID-19 pathology

    by Hiroshi Ueki, I-Hsuan Wang, Maki Kiso, Kenta Horie, Shun Iida, Sohtaro Mine, Michiko Ujie, Hung-Wei Hsu, Chen-Hui Henry Wu, Masaki Imai, et al.

    Microthrombus formation is associated with COVID-19 severity; however, the detailed mechanism remains unclear. In this study, we investigated mouse models with severe pneumonia caused by SARS-CoV-2 infection by using our in vivo two-photon imaging system. In the lungs of SARS-CoV-2-infected mice, increased expression of adhesion molecules in intravascular neutrophils prolonged adhesion time to the vessel wall, resulting in platelet aggregation and impaired lung perfusion. Re-analysis of scRNA-seq data from peripheral blood mononuclear cells from COVID-19 cases revealed increased expression levels of CD44 and SELL in neutrophils in severe COVID-19 cases compared to a healthy group, consistent with our observations in the mouse model. These findings suggest that pulmonary perfusion defects caused by neutrophil adhesion to pulmonary vessels contribute to COVID-19 severity.


  • Open Access

    Identification of novel wraparound transcripts in JC polyomavirus

    by Shun Iida, Kenta Takahashi, Sohtaro Mine, Tadaki Suzuki, Harutaka Katano

    JC polyomavirus (JCPyV) is a ubiquitous pathogen causing progressive multifocal leukoencephalopathy (PML) in immunocompromised individuals. Polyomaviruses (PyVs) utilize complex transcriptional regulation mechanisms to express diverse mRNAs from their compact, double-stranded circular DNA genomes. A recent study employed next-generation sequencing (NGS) to provide a detailed transcriptome atlas of PyVs, including BK polyomavirus and simian virus 40. However, detailed information regarding the JCPyV transcriptome remains limited. Here, we conducted a comprehensive analysis combining short-read and long-read NGS methods to unveil the detailed transcriptome atlas of JCPyV. RNA isolated from IMR-32 and 293 cells transfected with the circular JCPyV genome was analyzed by NGS, leading to the discovery of 39 novel viral transcripts in addition to 12 previously annotated ones. Among these novel transcripts, we identified characteristic wraparound transcripts, conserved across PyVs, which are constructed from long primary transcripts generated through continuous, multiple rounds of circular transcription of the viral genome. These wraparound transcripts included both late transcripts harboring leader-to-leader repeated sequences and SuperT transcripts containing multiple LxCxE motifs. Notably, wraparound transcripts, including a SuperT transcript, were also detected in brain tissues from PML patients. Collectively, this study significantly expands our understanding of the JCPyV transcriptome, revealing the expression of wraparound transcripts in PML lesions. These findings provide valuable insights into the molecular basis of JCPyV gene expression and PML pathogenesis, potentially facilitating the development of effective countermeasures against PML. Author Summary: JC polyomavirus (JCPyV) was first identified in 1971 from the brain tissue of a patient with progressive multifocal leukoencephalopathy (PML), a life-threatening neurological disease. Despite over 50 years since the pathogen’s identification, the prognosis for PML remains extremely poor due to the lack of effective therapeutics. Elucidating the JCPyV transcriptome can expand our understanding of viral gene expression and PML pathogenesis, potentially providing targets for novel therapeutic strategies. Here, we employed a combination of three next-generation sequencing technologies to explore novel viral transcripts, creating a detailed transcriptome atlas of JCPyV. We identified 39 novel viral transcripts in addition to the 12 previously annotated ones in cultured cells transfected with the JCPyV genome. These novel transcripts included wraparound transcripts, which arise from continuous, multiple rounds of circular transcription of the viral genome. Wraparound transcripts were characterized by the presence of tandem repeats of approximately 100 nucleotides. Notably, these characteristic wraparound transcripts were also detected in brain tissues from PML patients. Our study provides new insights into JCPyV gene expression, potentially contributing to the development of effective therapeutics.

  • Open Access

    An unusual cause of epigastric pain: Gastric syphilis

    by Naoya Itoh, Shun Iida, Masahiro Tajika

    (A) Gastroscopy showing multiple geographic erosions with white plaques from the angulus to the antrum. (B) Immunohistochemical staining for Treponema pallidum following gastric biopsy showing an abundance of brown syphilis spirochetes.


  • Open Access

    Draft genome sequence of Yersinia pseudotuberculosis isolated from a wild rat in Japan

    by Akiko Okutani, Masakatsu Taira, Shun Iida, Eun-Sil Park, Mikuni Tokuyoshi, Yuya Watari, Tadaki Suzuki, Ken Maeda

    We report a draft genome sequence of Yersinia pseudotuberculosis isolated from the spleen of a wild rat from Mikura-shima Island, Japan. The bacterium was identified as serotype O:4b using PCR-based O-genotyping. These genomic data provide insights into the pathogenic potential of this strain in spontaneous outbreaks among wild animals.

  • Open Access

    Development of a Mouse-Adapted Reporter SARS-CoV-2 as a Tool for Two-Photon In Vivo Imaging

    by Hiroshi Ueki, Maki Kiso, Yuri Furusawa, Shun Iida, Seiya Yamayoshi, Noriko Nakajima, Masaki Imai, Tadaki Suzuki, Yoshihiro Kawaoka

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) often causes severe viral pneumonia. Although many studies using mouse models have examined the pathogenicity of SARS-CoV-2, COVID-19 pathogenesis remains poorly understood. In vivo imaging analysis using two-photon excitation microscopy (TPEM) is useful for elucidating the pathology of COVID-19, providing pathological insights that are not available from conventional histological analysis. However, there is no reporter SARS-CoV-2 that demonstrates pathogenicity in C57BL/6 mice and emits sufficient light intensity for two-photon in vivo imaging. Here, we generated a mouse-adapted strain of SARS-CoV-2 (named MASCV2-p25) and demonstrated its efficient replication in the lungs of C57BL/6 mice, causing fatal pneumonia. Histopathologic analysis revealed the severe inflammation and infiltration of immune cells in the lungs of MASCV2-p25-infected C57BL/6 mice, not unlike that observed in COVID-19 patients with severe pneumonia. Subsequently, we generated a mouse-adapted reporter SARS-CoV-2 (named MASCV-Venus-p9) by inserting the fluorescent protein-encoding gene Venus into MASCV2-p25 and sequential lung-to-lung passages in C57BL/6 mice. C57BL/6 mice infected with MASCV2-Venus-p9 exhibited severe pneumonia. In addition, the TPEM of the lungs of the infected C57BL/6J mice showed that the infected cells emitted sufficient levels of fluorescence for easy observation. These findings suggest that MASCV2-Venus-p9 will be useful for two-photon in vivo imaging studies of the pathogenesis of severe COVID-19 pneumonia.


  • Open Access

    Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses

    by Sayaka Nagasawa, Yuichiro Hirata, Sho Miyamoto, Seiya Ozono, Shun Iida, Harutaka Katano, Shigeki Tsuneya, Kei Kira, Susumu Kobayashi, Makoto Nakajima, et al.

    High viral titers of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been detected in human corpses long after death. However, little is known about the kinetics of infectious SARS-CoV-2 in corpses. In this case series study, we investigated the postmortem kinetics of infectious SARS-CoV-2 in human corpses by collecting nasopharyngeal swab samples at multiple time points from six SARS-CoV-2-infected patients after their death. SARS-CoV-2 RNA was detected by quantitative reverse transcription-polymerase chain reaction from nasopharyngeal swab samples collected from all six deceased patients. A viral culture showed the presence of infectious virus in one deceased patient up to 12 days after death. Notably, this patient had a shorter time from symptom onset to death than the other patients, and autopsy samples showed pathological findings consistent with viral replication in the upper respiratory tract. Therefore, this patient died during the viral shedding phase, and the amount of infectious virus in the corpse did not decrease over time up to the date of autopsy (12 days after death). The findings of this study indicate that the persistence of SARS-CoV-2 in corpses can vary among individuals and may be associated with the stage of the disease at the time of death. These important results complement many previously reported findings on the infectivity of SARS-CoV-2 at postmortem.


  • Open Access

    Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters

    by Peter J. Halfmann, Kiyoko Iwatsuki-Horimoto, Makoto Kuroda, Yuichiro Hirata, Seiya Yamayoshi, Shun Iida, Ryuta Uraki, Mutsumi Ito, Hiroshi Ueki, Yuri Furusawa, et al.

    During the Omicron wave, previous variants such as BA.2, BA.4, and BA.5 were replaced by newer variants with additional mutations in the spike protein. These variants, BA.4.6, BQ.1.1, and XBB, have spread in different countries with different degrees of success. Here, we evaluated the replicative ability and pathogenicity of BA.4.6, BQ1.1, and XBB clinical isolates in male Syrian hamsters. Although we found no substantial differences in weight change among hamsters infected with these Omicron subvariants, the replicative ability of BQ.1.1 and XBB in lung tissue was higher than that of BA.4.6 and BA.5. Of note, BQ.1.1 was lethal in both male and female transgenic human ACE2 hamsters. In competition assays, XBB replicated better than BQ.1.1 in the nasal turbinate tissues of female hamsters previously infected with Omicron BA.2. These results suggest that newer Omicron subvariants in the XBB family are still evolving and should be closely monitored.